Recent Insider Transactions - Ligand Pharmaceuticals (NASDAQ: LGND)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ LGND Ligand Pharmaceuticals

Davis Todd C / director, officer: Chief Executive Officer

05/09/2025

Buy

$105.67

5,523

$584K

161,234

NASDAQ LGND Ligand Pharmaceuticals

Davis Todd C / director, officer: Chief Executive Officer

05/09/2025

Buy

$104.53

2,307

$241K

155,711

NASDAQ LGND Ligand Pharmaceuticals

Davis Todd C / director, officer: Chief Executive Officer

05/09/2025

Buy

$104.57

1,680

$176K

153,404

NASDAQ LGND Ligand Pharmaceuticals

Espinoza Octavio / officer: Chief Financial Officer

05/09/2025

Buy

$104.40

500

$52K

27,932

NASDAQ LGND Ligand Pharmaceuticals

Espinoza Octavio / officer: Chief Financial Officer

05/09/2025

Buy

$103.89

1,000

$104K

27,432